[תרגום מקצועי לעברית בהכנה — Professional Hebrew translation pending. See TRANSLATIONS.md]
Few topics in the wellness-technology space generate more optimistic claims than neurofeedback. Depending on who is writing, it is either a well-validated clinical intervention or an expensive pseudoscience. The truth, as usual, is more nuanced than either camp acknowledges — and understanding that nuance matters if you are a clinician deciding whether to offer a neurofeedback-adjacent service, or a patient deciding whether to try one.
Here is an honest account of what the evidence currently supports, what it does not, and how LiberateOS positions itself relative to that evidence base.
What neurofeedback is, briefly
Neurofeedback is a form of biofeedback in which the signal being fed back is derived from brain activity (typically EEG). The premise is that if people can see or hear a representation of their own brain state in real time, they can learn to modulate it — just as biofeedback for heart rate variability can help people learn to regulate their cardiovascular response to stress.
The core idea has been explored in research since the 1970s. The evidence base is uneven: some applications have better-quality research behind them than others, and the field has historically suffered from small sample sizes, lack of blinding, and variability in protocols and outcome measures.
Where the evidence is stronger
The best-studied application is ADHD. A 2019 meta-analysis in European Child and Adolescent Psychiatry found that neurofeedback produced significant improvements in inattention and hyperactivity, though effect sizes were smaller than those typically reported by open-label studies. A 2021 systematic review in Neuroscience and Biobehavioral Reviews reached similar conclusions — acknowledging genuine effects while calling for more rigorous double-blinded trials.
There is also reasonable evidence for applications in anxiety and stress reduction, performance enhancement in healthy populations (notably musicians and athletes), and as an adjunct in PTSD treatment protocols. The effect sizes are generally modest, and the evidence quality varies. "Promising but not conclusive" is an accurate summary for most wellness applications.
Where the evidence is weaker or contested
Claims for dramatic cognitive enhancement, disease treatment, or guaranteed therapeutic outcomes go well beyond what the current evidence supports. The neurofeedback field has faced legitimate criticism for overclaiming — for presenting effect sizes from unblinded studies as if they represent clinical certainty, and for extrapolating from specific clinical protocols to much broader claims about brain training in general.
For clinicians: be cautious about any neurofeedback product that claims to treat specific conditions, promises quantified outcome guarantees, or describes its mechanism as if it were established fact rather than working hypothesis. The honest position is that we have reasonable evidence for general improvements in self-regulation, calm, and focus under carefully designed protocols, and we do not yet fully understand the mechanism.
What VR adds
The combination of neurofeedback with virtual reality is newer, and the evidence base is therefore thinner. Early research is positive — a 2022 review in Frontiers in Human Neuroscience found that VR-based biofeedback environments produced engagement and sustained attention effects that non-immersive equivalents did not, and that the sense of presence in a VR environment may enhance the learning component of the feedback loop.
The mechanism proposed is intuitive: immersion increases the salience of the feedback environment, which may improve the signal-to-noise ratio of the learning process. If you are in a bland room watching a graph on a screen, the feedback is cognitively available but not engaging. If you are inside a responsive environment, the connection between your mental state and the world around you is more visceral and, arguably, more learnable.
This is a reasonable hypothesis supported by early data, not an established fact. We think it is a promising direction. We say "may" and "supports" in our marketing copy, not "proves" or "produces."
How LiberateOS is positioned
LiberateOS is a wellness platform. It is not a medical device. It does not make diagnostic or therapeutic claims. The language we use — "supports focus and calm," "may help build self-regulation skills," "evidence-aware wellness sessions" — is deliberately chosen to be defensible given the current state of the evidence.
We use consumer-grade EEG hardware, which produces useful but not clinical-grade signals. We are explicit about this with clinicians. The system is designed to support the clinician's workflow and the patient's wellness practice, not to substitute for clinical assessment or treatment.
Our position is this: the evidence for neurofeedback-based self-regulation support in wellness contexts is sufficient to justify offering these sessions as a complement to existing clinical practice, provided the framing is honest and the outcomes are not overclaimed. We designed the product around that position, and we hold to it in our marketing, our clinical training, and our ongoing product development.
If the evidence evolves — and we hope it will, with more rigorous studies — our claims will evolve with it. If specific applications are shown not to work, we will say so. That is what it means to be evidence-aware rather than evidence-selective.